Nav: Home

A seven-gene-deleted African swine fever virus is safe and effective vaccine in pigs

March 14, 2020

African swine fever (ASF) is a devastating infectious disease in swine and has been catastrophic for the global pig industry. In 2018, ASFV was transmitted to pigs in China and ten other Asian countries, which mauled heavily pig industry in these areas. The fact demonstrates that ASF is hard to be controlled by culling infected pigs alone in China, and the development and application of an efficacious vaccine is urgently needed. Different vaccine strategies for ASF have been evaluated in the past decades. Some gene-deleted attenuated ASFVs, but not Inactivated vaccines, DNA vaccines, subunit vaccines, and adenovirus-vectored vaccines, have shown potential as ASF vaccines, while it is not known if they could convert to more virulent strains during their replication in pigs. In the present study, Chen and his colleagues used the Chinese ASFV HLJ/18 as a backbone and generated a series of gene-deleted viruses (Figure 1), and demonstrated that HLJ/-18-7GD (genes encoding MGF505-1R, MGF505-2R, MGF505-3R, MGF360-12L, MGF360-13L, MGF360-14L, and CD2v deleted) is a safe and effective vaccine against ASFV.

The biggest concern with a live attenuated vaccine is whether the vaccine seed virus could convert to a virulent strain during replication in vaccinated animals. To evaluate the biosafety of HLJ/18-7GD, groups of SPF pigs were intramuscularly inoculated with 100 fold vaccine dose of HLJ/18-7GD and observed for 21 days. Blood samples were collected from the pigs on days 5, 10, and 15 p.i. and spleen and lymph nodes were collected from each pig euthanized on day 21 p.i. to detect viral DNA by qPCR. Viral DNA was not detected in any samples collected. All pigs survived without any ASF clinical signs during the three-week observation period. The authors blindly passed the viral DNA-negative blood of the HLJ/18-7GD-inoculated pigs for four more passages, but viral DNA was not detected in any samples collected from these pigs. To further investigate the replication of HLJ/18-7GD in pigs, 14 seven-week-old SPF pigs were inoculated with a limit dose (500 fold vaccine dose) of the virus, and two pigs were euthanized on days 2, 5, 8, 10, 12, 16, and 21 p.i., respectively. The blood and organs of these pigs were collected for viral DNA detection. Viral DNA was just detected in some lymph nodes of one or two pigs that were euthanized on days 5, 8, 10, 12, and 16 p.i.. The lymph nodes that had the highest viral DNA copies were homogenized and inoculated into four more pigs, and viral DNA was detected in two lymph nodes of one pig that was euthanized on day 10 p.i.. The virus was not detected in any subsequent pigs inoculated with the viral DNA-positive lymph node homogenates. These results indicate that, after intramuscular injection, the HLJ/18-7GD virus is only maintained for a short period in certain lymph nodes of pigs, and does not appear in the blood or any other organs of pigs; therefore, HLJ/18-7GD is highly unlikely to convert to a virulent strain during its replication in pigs.

Chen and his colleagues then evaluate the protective efficacy of HLJ/18-7GD in clean commercial pigs with intramuscular and oral challenge, respectively, as the oral route is how pigs are mainly infected with ASFV in nature. All of results demonstrated that HLJ/18-7GD provides similar protection in both farmed and SPF pigs. To evaluate the long-term protection of HLJ/18-7GD, a group of pigs were vaccinated once with 10 fold vaccine dose and challenged the pigs at 10 weeks post-vaccination. These results showed that the long-lasting immunity induced by a single dose of 10 fold vaccine dose of HLJ/18-7GD could provide solid protection against lethal ASFV challenge, which suggests that twice administrations of HLJ/18-7GD with the same high dose could protect pigs for their entire lives.

Chen and his colleagues also evaluated the safety of HLJ/18-7GD in pregnant sows, and found that all primiparous sows at different pregnant stages inoculated with 10 fold vaccine dose of HLJ/18-7GD remained healthy and delivered their piglets on the expected dates, indicating that inoculation with HLJ/18-7GD will not cause disease or abortion in pregnant sows or affect the health of the piglets.

The HLJ/18-7GD does not grow in any cell lines, which means that the vaccine must be produced in primary cells. HLJ/18-7GD grows well in porcine bone marrow cells (PBMs) and at least 200,000 doses of vaccine could be produced from PBMs derived from one piglet. Therefore, using these primary cells for large-scale production of HLJ/18-7GD is feasible and cost-effective.

These important results confidently presented the evidence that HLJ/18-7GD is safe and effective against ASFV, which will play an important role in the control of ASFV.
See the article: Chen, W., Zhao, D., He, X., et al. (2020). A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Sci China Life Sci, in press,

Science China Press

Related Lymph Nodes Articles:

Unveiling how lymph nodes regulate immune response
The Hippo pathway keeps lymph nodes' development healthy. If impaired, lymph nodes become full of fat cells or fibrosis develops.
Sentinel lymph node biopsy has no benefits for stage zero breast cancer
Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found.
S1P molecule regulates dendritic cell localization and vascular integrity in lymph nodes
Researchers found that HEVs, which were deficient for the S1P-transporter Spinster-homologue-2, were unable to attract dendritic cells in order to trigger LTβr-signaling through cell-cell contact with HEVs.
Fewer lymph node operations for breast cancer patients with new prediction models
In recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personalised treatment of lymph nodes in breast cancer patients.
Nanoparticle therapy targets lymph node metastases
Metastasis, in which cancer cells break free from the primary tumor and form tumors at other sites, worsens the prognosis for many cancer patients.
Lymph nodes can predict survival in patients with esophageal cancer
It is difficult for physicians to estimate recurrence and survival in patients with esophageal cancer.
A peek into lymph nodes
The vast majority of cancer deaths occur due to the spread of cancer from one organ to another, which can happen either through the blood or the lymphatic system.
Lymph nodes are niches for prolonged tuberculosis infection
Lymph nodes can contain large numbers of tuberculosis-causing bacteria and serve as long-term reservoirs of bacterial persistence, according to a study published Nov.
Lymph node structural cells rein in human immune responses
New research published in PLOS Biology by Anne Fletcher and Konstantin Knoblich and colleagues, from Monash Biomedicine Discovery Institute (BDI), has veered away from traditional immunology by turning the spotlight on the structural cells that build and support the immune-rich environment of lymph nodes.
Newly identified structure in lymph nodes was 'hiding in plain sight'
For the first time in decades, researchers have identified a new 'micro-organ' within the immune system -- and they say it's an important step towards understanding how to make better vaccines.
More Lymph Nodes News and Lymph Nodes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at